AVANIR PHARMACEUTICALS (AVNR)

[rogerm]

If you liked AVNR then take a look at CNCE. Otsuka bought out AVNR and decided to go with the CNCE deuterated AVP-786 for their two P3s in Alz behavior and also testing the drug in a P2 for MDD. CNCE will derive royalty and milestones if the drug succeeds. The P2 for the QDM drug had very good results so I expect to see good P3 numbers. CNCE also has a P1 deuterated version of VRTX's Kalydeco which is expected to become a multi-billion Cystic Fibrosis drug.

[markjohn62]

Yep, 17

[kenjen43]

What has become of AVNR stock?. Were they bought out?

[neverfinished]

what happened here?

[SPORTSPROPHET]

BOY DID I SCREW THIS ONE UP

[sts66]

Oopsie....13,827,419 shorts got stuck on the wrong side of AVNR....

http://www.nasdaq.com/symbol/avnr/short-interest

[sts66]

Oops.....sorry, my crystal ball was in the shop, didn't know a BO was coming....that's why there was such strong support at $15 despite a possible CRL......the street always knows what the little guy doesn't.

[bmiggidy]

Hahahhha

[bmiggidy]

Hahaha

[sts66]

What is this guy smoking? Raises PT to $20 despite saying no other bidders are in sight?

Cowen analyst Ritu Baral maintained an Outperform rating on Avanir Pharmaceuticals (NASDAQ:AVNR) with a $20 price target, following the news that the company has entered into a definitive agreement with Otsuka Pharmaceutical pursuant to which Otsuka will acquire Avanir for $17.00 per share in cash.

Baral observed, “We see this as an underwhelming offer but see no evidence of other bidders before the tender offer begins in 10 business days and the close of the transaction in 1Q15.

[sts66]

Quite a bit of trading for 3 days from the announcement will be short covering and margin calls - short interest was supposedly 15M shrs as of 11/14 but 27.4M shorted shrs covered yesterday - makes you go "hmmmm", eh? No such thing as naked shorts, LOL? And 8M shrs were newly shorted - nearly 44% of total trade volume of 82M yesterday was short covering/new shorts:

http://www.shortanalytics.com/getshortchart.php?tsymbol=avnr

A lot of folks bought $17 calls too, hoping for a 2nd bidder - volume yesterday was 13.3k contracts, OI now 14.3k - for 10 cents yesterday (5 cents today) a cheap gamble:

http://www.optionistics.com/quotes/option-prices

As per holding vs. selling, Otsuka said tender offer goes out in 10 business days - not sure if a 2nd bidder can enter after that process starts, but doubt it. You'll only get the max $17 if you tender your shares - stock is currently trading at $16.91, and it'll stay between $16.90 - $16.96 or so until the deal is completed next year - every stock I've had bought out sold on the open market for less than the BO price until the stock was delisted - dunno why, but it's happened every time.

Last one I had was FWLT - BO price was originally ~ $34/shr, with $16 cash per share of FWLT and .8998 shares of the British company AMEC, or $32 cash/shr FWLT - I sold all my shares at $33.94 2 months after the deal was announced after no other buyers emerged. But because of international merger rules, deal had to pass scrutiny of US and EU governments. Meanwhile, several quarters flew by, with FWLT and AMEC stock price dropping on lower earnings - AMEC shrs have dropped 23% in value since I sold, anyone who selected $16 cash + shrs of AMEC got screwed. Not saying that will happen with AVNR because it's currently an all cash deal, but watch out if someone else makes a cash + shrs offer.

I also hope that Otsuka doesn't raise the price of Nuedexta to maximize the BO value - I know AVNR has raised the price at least once already - I take N very rarely, but just one scrip is worth 25% of drug costs before hitting the Medicare donut hole - that's huge - and I'm nearly out of the scrip I got 3 yrs ago, will either need a refill in 2015 or consider not taking it anymore, which would suck for those rare times I do need it (temporary CNS issues). Works great, BTW

[maytepper]

$AVNR Cowen Comments On Avanir Pharmaceuticals Following Otsuka Acquisition http://www.smarteranalyst.com/2014/12/03/cowen-comments-on-avanir-pharmaceuticals-following-otsuka-acquisition/

[Dennisb68]

I believe a lot of investors believe this is going higher than $17 or they wouldn't be so actively buying so close to $17 as they have been. I don't see it selling for less than $17 so why not hold for awhile.

[Skeetz99]

Why would anyone sell now based on a $17 all cash offer. I would wait for another bidder to surface and defer any 2014 capital gains taxes...could be a $21 ++ offer within days or weeks.

[expediter13]

those were calls....

[sts66]

Retail owns ~ 20M shares, so obviously lots of the churn is 'tutes locking in profits for Q4/14 - if they're selling, might want to follow their lead? Gotta wonder if Baker Bros had some inside info, buying almost 12M shares on Oct 6th - a week before the AVP-923 data was released to the public - also made them the largest owner:

http://money.cnn.com/quote/shareholders/shareholders.html?symb=AVNR&subView=institutional

Not going to rec what you should do, as previous "take some off the table" recs obviously would have cost folks money, but then again I wasn't really following the oddness of the pps action either, which in retrospect certainly showed something unknown was going on. All I'll say is what I've done when stocks I owned announced BO's - hold for a bit to see if another higher offer comes in - and if not, sell to fit your tax situation, or to buy another stock that you think is undervalued, as you're not going to get more than the original offer. Unfortunately, with only 10 days in this case, you can't manage taxes for this one, you're going to have a large tax bill to pay in 2015, a nice problem to have - at least you have some time left to sell some losers to offset some cap gains.

I've had something close to 8-9 stocks bought out from under me, and only 2 of them made me a profit - low pps made them targets and they got stolen from shareholders. Mergers and stock/cash deals make it even more complicated, tax headaches for cost basis in the new stock if you don't bail before the deal is final. Currently have that problem - RFMD is merging with TQNT - I'm up almost 100% on RFMD, but post-merger the new company is supposed to be worth double what RFMD trades for now - but it's in my IRA, so no tax issues, just "is it so high because of merger fever?", or is the new combined company actually going to be worth as much as analysts project?

[expediter13]

I dont know if to sell it now and move on or just hold on and see what happens.... 67M shares trading haNDS. That is more than retail own....

[Dennisb68]

Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Otsuka Pharmaceutical Co., Ltd.
http://finance.yahoo.com/news/avanir-pharmaceuticals-inc-shareholder-alert-172400231.html

[sts66]

I just knew something was wrong when the FDA sent a clear warning shot across the bow about optinase this close to PDUFA and the stock didn't budge - in normal situations it should have dropped 10%-30% on what might be a CRL. Obviously the street was aware that a buyout was on the table, pps movement proves that - congrats to those who held!

Wishing the same for my longest held bio, POZN, on PA approval in a few weeks, still might happen - they broke up with their distribution partner Sanofi, now have to find another - or perhaps someone is looking to buy them too, which makes sense - company has no pipeline, cut staff to the bone, was only going to be a holding company distributing a cut of the profits to shareholders. Market didn't like the news yesterday, down -20% (recall same did not happen when AVNR got bad news), but up 10% today, although on low volume.

[PAC]

looks like north 17 it likely is

[Skeetz99]

Management wants to protect their jobs; hence, they took a lower buyout offer. We will see how the PPS reacts; it will need to move north of $17 if a white knight will pursue at a higher prices.

I want $21-$22....fair value as of today and what the Wall street analysts had as a price target.

[PAC]

AVNR $17 buyout

[maytepper]

$AVNR Cowen Remains Positive On Avanir Pharmaceuticals Following FDA CRL For AVP-825 http://www.smarteranalyst.com/2014/12/01/cowen-reiterates-remains-positive-on-avanir-pharmaceuticals-following/

[seekingjustice2]

STS, no offense but you sold at $3.28, right?

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=81341504

And since then you've been periodically telling us to sell shares. Your latest sell thesis is based upon the claim that optinose is the reason for the latest run without the slightest mention of the agitation elephant standing smack dab in front of you.

[sts66]

The strength here is amazing - where was it when I owned the damn stock, LOL? missing in action, that's where! Just can't see how this price is being supported by anything other than pre-PDUFA speculators, and would expect a big profit taking drop after approval of the nasal drug, assuming the "user issues" are easily solved. If I owned I'd be nervous about such a huge climb when the company is still losing money in bunches - not rec'ing what anyone should do, but after seeing paper gains of 200% and 350% in SDRL and GLNG vaporize over the last couple months (now RED in SDRL by -1%, unreal), if I still owned I'd be up 250% here and absolutely would be trimming - greed kills, I'm living proof, unfortunately. Of course you guys don't have Obama and Putin + OPEC vs. US shale drillers in death match fights to worry about......

[seekingjustice2]

tradeherpete, no objection to you getting onboard as planned (would be joining you). sts is the eternal pessimist, I'm the eternal optimist, so there's lots of middle ground for you to occupy.

[tradeherpete]

sts and Justice,

This stock is a marvel. So strong yet there is a trigger finger that can pull that red line down so quick it makes you wonder. Not for long but substantially and quickly.

I don't need a lot of time. 3 or 4 seconds would be fine. I've got a buy order at 12.40 which seemed a pipe dream after this week but... you never know!

The bigger they are, the harder they fall, one and all...I can hope right?

[stocktrademan]

$AVNR DD Notes ~ http://www.ddnotesmaker.com/AVNR

bullish

$AVNR recent news/filings

## source: finance.yahoo.com

Thu, 27 Nov 2014 15:50:01 GMT ~ Avanir's Migraine Drug Gets Complete Response Letter


read full: http://finance.yahoo.com/news/avanirs-migraine-drug-gets-complete-155001399.html
*********************************************************

Wed, 26 Nov 2014 23:13:09 GMT ~ Avanir to Provide More Human-Factor Data for Migraine Treatment


read full: http://online.wsj.com/articles/avanir-to-provide-more-human-factor-data-for-migraine-treatment-1417043588?mod=yahoo_hs
*********************************************************

Wed, 26 Nov 2014 22:30:44 GMT ~ FDA rejects Avanir's migraine drug-device

[Reuters] - The U.S. Food and Drug Administration rejected Avanir Pharmaceuticals Inc's migraine drug device, a few weeks after the regulator had raised questions regarding some data submitted as part of the marketing ...

read full: http://finance.yahoo.com/news/fda-rejects-avanirs-migraine-drug-223044949.html
*********************************************************

Wed, 26 Nov 2014 22:19:16 GMT ~ Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA

[at noodls] - ALISO VIEJO, Calif., Nov. 26, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to ...

read full: http://www.noodls.com/view/2288BD954A2885025DEFFA606449D3972347BCC9
*********************************************************

Wed, 26 Nov 2014 21:57:00 GMT ~ 4:57 pm Avanir Pharmaceuticals receives Complete Response Letter from FDA on AVP-825


read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#avnr
*********************************************************


$AVNR charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$AVNR company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/AVNR/company-info
Ticker: $AVNR
OTC Market Place: Not Available
CIK code: 0000858803
Company name: Avanir Pharmaceuticals, Inc.
Company website: http://www.avanir.com
Incorporated In: CA, USA


$AVNR share structure

## source: otcmarkets.com

Market Value: $2,579,206,801 a/o Nov 26, 2014
Shares Outstanding: 171,832,565 a/o Jul 31, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$AVNR extra dd links

Company name: Avanir Pharmaceuticals, Inc.
Company website: http://www.avanir.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AVNR+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AVNR+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AVNR+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AVNR/news - http://finance.yahoo.com/q/h?s=AVNR+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AVNR/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AVNR/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AVNR+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AVNR
DTCC (dtcc.com): http://search2.dtcc.com/?q=Avanir+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Avanir+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Avanir+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.avanir.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.avanir.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.avanir.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AVNR
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000858803&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AVNR/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AVNR/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AVNR&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AVNR
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AVNR/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AVNR+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AVNR+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AVNR
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AVNR
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AVNR+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AVNR/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AVNR+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AVNR.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AVNR
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AVNR/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AVNR
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AVNR
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AVNR:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AVNR
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AVNR



$AVNR DD Notes ~ http://www.ddnotesmaker.com/AVNR

[seekingjustice2]

Everyone who has guessed against the strength of the buying since this stock started to run has been wrong (I'm talking about the bigger correction predictions), so my guess stays the same as it has been since the explosion occurred: not a significant downside, which has had me buying more. Sorry (but it is just a guess after all :0).

It has run hard since the first FDA request for more data on Optinose, which strongly suggests that it is the agitation market that is driving the price recently. Who is going to sell when so much big money is buying?

[terragord7]

key issues safety fine efficacity fine, just need to address the device for human errors, purely a product design issue. MOst analysts think non issue

[terragord7]

but why ihub says last trade 815 for 15,05

[sts66]

I would have been certain a large haircut was in store after the CRL, which I predicted was coming - FDA raised similar issues with MNKD's delivery device at least twice before final approval - but AH trading shows no plunge - very weird. Perhaps this long sustained runup was due more to the AZ drug and not the inhalable sumatriptan? Will see how it plays out Friday - perhaps traders are too busy prepping for Turkey Day, not at their terminals this evening.

[tradeherpete]

Any guesses as to what it may retreat to in the near term due to the FDA delay?

I would like to re-enter after having had a spaz attack on the initial news and selling. A costly mistake. tia

[seekingjustice2]

15.00 on low volume. Lovely chart. Short interest up a bit too, will be interesting to see how 14.9 million shares get covered with such strong buying. Happy Thanksgiving longs.

[expediter13]

Glad I got back in at 11.25. i was going to hold out for more 10s. Think I am going to jump in more here. I know a market correction is coming, has too...

[Prudent Capitalist]

Agree on no buyout. And you have been right on target with your analysis here expediter.

[maytepper]

$AVNR Deutsche Bank Maintains Buy On Avanir Pharmaceuticals Following CTAD Conference http://www.smarteranalyst.com/2014/11/24/deutsche-bank-maintains-buy-on-avanir-pharmaceuticals-following-ctad-conference/

[expediter13]

Maintaining very well. Strong stock, just hope for no buyout

[sts66]

Rhe-rho....shades of MNKD FDA troubles appear to be showing here....how nice of them to wait until a week before the PDUFA to inform AVNR of their concerns, the jerks:

http://www.prnewswire.com/news-releases/avanir-pharmaceuticals-announces-preliminary-feedback-from-the-fda-on-avp-825-for-the-acute-treatment-of-migraine-281907091.html

ALISO VIEJO, Calif., Nov. 7, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S. Food and Drug Administration (FDA) has issued preliminary written feedback to its New Drug Application (NDA) for AVP-825. AVP-825 is a drug-device combination product consisting of low-dose sumatriptan powder, delivered intranasally utilizing a novel Breath Powered delivery technology. The FDA has raised questions regarding the human factor validation study data submitted as part of the NDA. Human factor testing focuses on the interactions between people and devices. The goal of human factor testing is to evaluate use-related risks and confirm that users can use the device safely and effectively. Although the NDA review is ongoing, Avanir has concluded, at this time, that approval of AVP-825 may be unlikely by the PDUFA date of November, 26, 2014.

The FDA feedback was provided via a Discipline Review letter, which is a standard vehicle to convey early thoughts on possible deficiencies of an application. In the letter, the FDA requested that the company optimize the product-user interface and conduct additional human factor testing. In addition, the FDA commented that the NDA review is not complete and that they may have additional comments regarding the application.

[stocktrademan]

$AVNR DD Notes ~ http://www.ddnotesmaker.com/AVNR

bullish

$AVNR recent news/filings

## source: finance.yahoo.com

Wed, 12 Nov 2014 21:48:45 GMT ~ AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers


read full: http://biz.yahoo.com/e/141112/avnr8-k.html
*********************************************************

Wed, 12 Nov 2014 13:00:02 GMT ~ Avanir's AVP-825 Approval Could be Delayed (Revised)


read full: http://finance.yahoo.com/news/avanirs-avp-825-approval-could-130002635.html
*********************************************************

Mon, 10 Nov 2014 21:40:02 GMT ~ Avanir Faces Regulatory Setback, AVP-825 Could Be Delayed


read full: http://finance.yahoo.com/news/avanir-faces-regulatory-setback-avp-214002683.html
*********************************************************

Fri, 07 Nov 2014 21:28:00 GMT ~ Another lackluster session for major equities


read full: http://finance.yahoo.com/tumblr/blog-another-lackluster-session-for-major-equities-212810212.html
*********************************************************

Fri, 07 Nov 2014 20:04:49 GMT ~ AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits


read full: http://biz.yahoo.com/e/141107/avnr8-k.html
*********************************************************


$AVNR charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$AVNR company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/AVNR/company-info
Ticker: $AVNR
OTC Market Place: Not Available
CIK code: 0000858803
Company name: Avanir Pharmaceuticals, Inc.
Company website: http://www.avanir.com
Incorporated In: CA, USA


$AVNR share structure

## source: otcmarkets.com

Market Value: $2,256,161,578 a/o Nov 18, 2014
Shares Outstanding: 171,832,565 a/o Jul 31, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$AVNR extra dd links

Company name: Avanir Pharmaceuticals, Inc.
Company website: http://www.avanir.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AVNR+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AVNR+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AVNR+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AVNR/news - http://finance.yahoo.com/q/h?s=AVNR+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AVNR/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AVNR/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AVNR+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AVNR
DTCC (dtcc.com): http://search2.dtcc.com/?q=Avanir+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Avanir+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Avanir+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.avanir.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.avanir.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.avanir.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AVNR
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000858803&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AVNR/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AVNR/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AVNR&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AVNR
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AVNR/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AVNR+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AVNR+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AVNR
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AVNR
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AVNR+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AVNR/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AVNR+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AVNR.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AVNR
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AVNR/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AVNR/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AVNR
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AVNR
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AVNR:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AVNR
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AVNR



$AVNR DD Notes ~ http://www.ddnotesmaker.com/AVNR

[expediter13]

He is either a flipper or swing trader. He is always reading the NOW news and trying to jump in and out. Just a guess, this company has moved so much people think that is it, or can grab one move then move out. They don't know Baker bought so many shares. This can't move off of 25 at the very least if you own it. A buy-out of 25 very least price. Or it moves to that pirce next year. Where else can you double your money in less than a year ? Nowhere. Baker doesn't make mistake. i follow them...

[budgetthis]

Great post, expediter !!!

Neck, we're up $.07 cents currently, in the low $13's.....we have had a great run..... and still much room to go, imho.

Budget

[expediter13]

It went from 5.50 to 11, to 12, to 13.... All on phase II data and an offering that added millions of sahres and you want even more ?

Baker Bros are the ones buying up shares going from 18M share to over 30M shares. i dont know what more someone could want out of a company that is trading on promise, not numbers. It is not like they have huge revnue already.

All i can say is you better hold it, and hold it for a while. Sell it if your a day trader and can't live without a 50% profit every week.

[JohnDee123]

This become so unpredictable, failed breakout, now fails to gap down, volume steady and action is still sideaways. So I swapped it to DUST to earn some today..:/

[expediter13]

I hope it dips really far...

[JohnDee123]

there's lot of fake bid, all algo driven today..no real people trade this obviously.. so i worry it can dip hard.

[expediter13]

Bring it on Down !

[$$$eeker]

$AVNR Likely targets, investors and bankers said, are companies with one or two promising new products, such as Avanir Pharmaceuticals Inc (AVNR.O), which has an Alzheimer's drug under patent; San Diego-based Neurocrine Biosciences Inc (NBIX.O), which has partnered with Abbvie on an endometriosis treatment; and Puma Biotechnology Inc (PBYI.N), which is developing a breast cancer drug.

All three companies are rumored to be the object of takeover deals in the next few months. None responded to requests for comment.







http://reut.rs/1GufGRc

[Percysixstargazer]

http://seekingalpha.com/news/2095035-avanir-moves-up-on-takeout-speculation?uprof=46&dr=1#email_link


Percy (Newbe)

[expediter13]

Guess the russell 2000 is adding them today. 1.4M shares or so. THis migrane thing seems a bit off, Just my Opinion.... I dont understand it so much. That may be the problem :)

Basically a puffer to inject powder direct into sinus. Think the should concentrate on the depression phhase II AVP-786 Major Depression. If we seen a jump on 923 for ALZ patients, Imagine what it would do as a depression drug PPS wise. The part of it that is great is the offshoot of the 923 study showed depression was good. I can't find it, seen it in a post...

Depression would be a much bigger pay day.... Bad results wil lbring it down, think they would hold off on that... I also think that the Banks that made the offering know it works, thus they bought...